Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Hepatitis

  Free Subscription


12.03.2018

1 AIDS
1 Ann Intern Med
1 Blood
1 BMC Cancer
2 Clin Infect Dis
1 Dig Dis Sci
3 Eur J Gastroenterol Hepatol
2 Gut
1 Hepatology
1 J Clin Gastroenterol
1 J Clin Microbiol
5 J Hepatol
1 J Med Virol
1 J Viral Hepat
1 J Virol
2 Lancet
2 N Engl J Med
2 PLoS One
1 PLoS Pathog
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. ISMAIL MF, Wong DK, Bogoch II
    The role for hepatitis A vaccination in HIV pre-exposure prophylaxis.
    AIDS. 2018;32:675-676.
    PubMed     Text format    


    Ann Intern Med

  2. DURAND CM, Bowring MG, Brown DM, Chattergoon MA, et al
    Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.
    Ann Intern Med. 2018 Mar 6. pii: 2674335. doi: 10.7326/M17-2871.
    PubMed     Text format     Abstract available


    Blood

  3. HAMMOND SP, Chen K, Pandit A, Davids MS, et al
    Risk of hepatitis B virus reactivation in patients treated with ibrutinib.
    Blood. 2018 Feb 28. pii: blood-2018-01-826495. doi: 10.1182/blood-2018-01-826495
    PubMed     Text format    


    BMC Cancer

  4. RAMADORI G, Bosio P, Moriconi F, Malik IA, et al
    Case report: 8 years after liver transplantation: de novo hepatocellular carcinoma 8 months after HCV clearance through IFN-free antiviral therapy.
    BMC Cancer. 2018;18:257.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  5. KLEINSTEIN SE, Shea PR, Stamm LM, Sulkowski M, et al
    Association of CYP2B6 Single-Nucleotide Polymorphisms Altering Efavirenz Metabolism With Hepatitis C Virus (HCV) Treatment Relapse Among Human Immunodeficiency Virus/HCV-Coinfected African Americans Receiving Ledipasvir/Sofosbuvir in the ION-4 Trial.
    Clin Infect Dis. 2018 Mar 7. pii: 4705930. doi: 10.1093/cid/cix1051.
    PubMed     Text format     Abstract available

  6. MOGALIAN E, Stamm LM, Osinusi A, Brainard DM, et al
    Drug-Drug Interactions Studies between HCV Antivirals Sofosbuvir/Velpatasvir and Boosted and Unboosted HIV Antiretroviral Regimens in Healthy Volunteers.
    Clin Infect Dis. 2018 Mar 7. pii: 4924529. doi: 10.1093.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  7. HU KQ, Cui W
    Persistence of Circulating Hepatitis C Virus Antigens-Specific Immune Complexes in Patients with Resolved HCV Infection.
    Dig Dis Sci. 2018 Mar 8. pii: 10.1007/s10620-018-4968.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  8. VEIGA ZST, Villela-Nogueira CA, Fernandes FF, Cavalcanti MG, et al
    Transient elastography evaluation of hepatic and spleen stiffness in patients with hepatosplenic schistosomiasis.
    Eur J Gastroenterol Hepatol. 2017;29:730-735.
    PubMed     Text format     Abstract available

  9. KOBAYASHI N, Iijima H, Tada T, Kumada T, et al
    Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response.
    Eur J Gastroenterol Hepatol. 2018 Feb 28. doi: 10.1097/MEG.0000000000001106.
    PubMed     Text format     Abstract available

  10. EFE C, Ozaslan E, Purnak T
    Second-line immunosuppressants for autoimmune hepatitis.
    Eur J Gastroenterol Hepatol. 2018;30:490-491.
    PubMed     Text format    


    Gut

  11. LIN HH, Tseng TC, Kao JH
    Large and middle hepatitis B surface antigen: the lower the better?
    Gut. 2018 Mar 7. pii: gutjnl-2018-316030. doi: 10.1136/gutjnl-2018-316030.
    PubMed     Text format    

  12. MURATA K, Asano M, Matsumoto A, Sugiyama M, et al
    Induction of IFN-lambda3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection.
    Gut. 2018;67:362-371.
    PubMed     Text format     Abstract available


    Hepatology

  13. VAN CAMPENHOUT MJH, van Bommel F, Pfefferkorn M, Fischer J, et al
    Host and viral factors associated with serum hepatitis B virus RNA levels among patients in need for treatment.
    Hepatology. 2018 Mar 7. doi: 10.1002/hep.29872.
    PubMed     Text format     Abstract available


    J Clin Gastroenterol

  14. PENG S, Wan Z, Liu T, Zhu H, et al
    Incidence and Risk Factors of Intrauterine Transmission Among Pregnant Women With Chronic Hepatitis B Virus Infection.
    J Clin Gastroenterol. 2018 Mar 6. doi: 10.1097/MCG.0000000000001001.
    PubMed     Text format     Abstract available


    J Clin Microbiol

  15. WANG B, Harms D, Papp CP, Niendorf S, et al
    Comprehensive Molecular Approach for Characterization of Hepatitis E Virus Genotype 3 Variants.
    J Clin Microbiol. 2018 Mar 7. pii: JCM.01686-17. doi: 10.1128/JCM.01686.
    PubMed     Text format     Abstract available


    J Hepatol

  16. MOHS A, Kuttkat N, Reissing J, Zimmermann HW, et al
    Functional role of CCL5/RANTES for HCC progression during chronic liver disease.
    J Hepatol. 2017;66:743-753.
    PubMed     Text format     Abstract available

  17. YU X, Lan P, Hou X, Han Q, et al
    HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1beta production via suppressing the NF-kappaB pathway and ROS production.
    J Hepatol. 2017;66:693-702.
    PubMed     Text format     Abstract available

  18. PETTA S, Adinolfi LE, Fracanzani AL, Rini F, et al
    Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis.
    J Hepatol. 2018 Mar 2. pii: S0168-8278(18)30132.
    PubMed     Text format     Abstract available

  19. DELTENRE P, Marot A, Dubois M, Trepo E, et al
    Assessment of the risk of alcohol relapse following liver transplantation for alcoholic hepatitis using a meta-analysis approach.
    J Hepatol. 2018 Mar 2. pii: S0168-8278(18)30142.
    PubMed     Text format    

  20. LUTHER J, Dienstag JL
    Reply: Assessment of the risk of alcohol relapse following liver transplantation for alcoholic hepatitis using a meta-analysis approach.
    J Hepatol. 2018 Mar 2. pii: S0168-8278(18)30141.
    PubMed     Text format    


    J Med Virol

  21. ANTONIO UL, Alicia OM, Antonio MJ, Elena GM, et al
    Presence of rare hepatitis C virus subtypes, 2j, 2k and 2r, in Mexico City as identified by sequencing.
    J Med Virol. 2018 Mar 6. doi: 10.1002/jmv.25070.
    PubMed     Text format     Abstract available


    J Viral Hepat

  22. PAPATHEODORIDIS GV, Hatzakis A, Cholongitas E, Baptista-Leite R, et al
    Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
    J Viral Hepat. 2018;25 Suppl 1:6-17.
    PubMed     Text format     Abstract available


    J Virol

  23. RIVA L, Song OR, Prentoe J, Helle F, et al
    IDENTIFICATION OF PIPERAZINYLBENZENESULFONAMIDES AS NEW INHIBITORS OF CLAUDIN-1 TRAFFICKING AND HEPATITIS C VIRUS ENTRY.
    J Virol. 2018 Feb 28. pii: JVI.01982-17. doi: 10.1128/JVI.01982.
    PubMed     Text format     Abstract available


    Lancet

  24. WANDELER G, Coffie PA, Kuniholm MH, Ocama P, et al
    Issues with measuring hepatitis prevalence in resource-limited settings.
    Lancet. 2018;391:835-836.
    PubMed     Text format    

  25. MOIN A, Fatima H, Qadir TF
    Tackling hepatitis C-Pakistan's road to success.
    Lancet. 2018;391:834-835.
    PubMed     Text format    


    N Engl J Med

  26. JOURDAIN G, Ngo-Giang-Huong N, Harrison L, Decker L, et al
    Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
    N Engl J Med. 2018;378:911-923.
    PubMed     Text format     Abstract available

  27. DUSHEIKO G
    A Shift in Thinking to Reduce Mother-to-Infant Transmission of Hepatitis B.
    N Engl J Med. 2018;378:952-953.
    PubMed     Text format    


    PLoS One

  28. MAPOURE NY, Budzi MN, Eloumou SAFB, Malongue A, et al
    Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study.
    PLoS One. 2018;13:e0192406.
    PubMed     Text format     Abstract available

  29. BALSITIS S, Gali V, Mason PJ, Chaniewski S, et al
    Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infection.
    PLoS One. 2018;13:e0190058.
    PubMed     Text format     Abstract available


    PLoS Pathog

  30. DOUAM F, Fusil F, Enguehard M, Dib L, et al
    A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism.
    PLoS Pathog. 2018;14:e1006908.
    PubMed     Text format     Abstract available


    Vaccine

  31. MARTINON-TORRES F, Boisnard F, Thomas S, Sadorge C, et al
    Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
    Vaccine. 2017 Jun 2. pii: S0264-410X(17)30679.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: